ANI Pharmaceuticals | Passivo Circulante



Current Liabilities Alterar Data
AbbVie USD 38.75B 4.31B 2024-12
ANI Pharmaceuticals USD 193.68M 3.75M 2024-12
Aurora Cannabis CAD 149.81M 40.71M 2024-12
Canopy Growth CAD 97.02M 184.27M 2024-12
Eli Lilly USD 28.38B 3.7B 2024-12
Hikma Pharmaceutical USD 1.38B 41M 2024-06
Knight Therapeutics CAD 118.15M 12.32M 2024-09
Novartis USD 28.69B 560M 2024-12
Perrigo USD 1.04B 406.3M 2024-12
Sun Pharmaceuticals INR 172.55B 2.71B 2024-09
Teva Pharmaceutical Industries USD 12.8B 1B 2024-12



ANI Pharmaceuticals Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2025.